Pfizer (NSE:PFIZER) Gross Margin % : 66.19% (As of Dec. 2023)

View and export this data going back to 1999. Start your Free Trial

What is Pfizer Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Pfizer's Gross Profit for the three months ended in Dec. 2023 was ₹3,574 Mil. Pfizer's Revenue for the three months ended in Dec. 2023 was ₹5,400 Mil. Therefore, Pfizer's Gross Margin % for the quarter that ended in Dec. 2023 was 66.19%.

The historical rank and industry rank for Pfizer's Gross Margin % or its related term are showing as below:

NSE:PFIZER' s Gross Margin % Range Over the Past 10 Years
Min: 59.49 Med: 62.9 Max: 64.36
Current: 63.08

During the past 13 years, the highest Gross Margin % of Pfizer was 64.36%. The lowest was 59.49%. And the median was 62.90%.

NSE:PFIZER's Gross Margin % is ranked better than
77.27% of 990 companies
in the Drug Manufacturers industry
Industry Median: 46.705 vs NSE:PFIZER: 63.08

Pfizer had a gross margin of 66.19% for the quarter that ended in Dec. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Pfizer was 0.40% per year.

Pfizer Gross Margin % Historical Data

The historical data trend for Pfizer's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pfizer Gross Margin % Chart

Pfizer Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Gross Margin %

Get a 7-Day Free Trial

64.07

63.17

64.36

63.69

63.97

Pfizer Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Gross Margin %	Get a 7-Day Free Trial															65.07	62.28	59.37	64.40	66.19

Competitive Comparison of Pfizer's Gross Margin %

For the Drug Manufacturers - General subindustry, Pfizer's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pfizer's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pfizer's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Pfizer's Gross Margin % falls into.

Pfizer Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Pfizer's Gross Margin for the fiscal year that ended in Mar. 2023 is calculated as

Gross Margin % (A: Mar. 2023 )	=	Gross Profit (A: Mar. 2023 )	/	Revenue (A: Mar. 2023 )
	=	15510.9	/	24247.6
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(24247.6 - 8736.7)	/	24247.6
	=	63.97 %

Pfizer's Gross Margin for the quarter that ended in Dec. 2023 is calculated as

Gross Margin % (Q: Dec. 2023 )	=	Gross Profit (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	3574.1	/	5399.7
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(5399.7 - 1825.6)	/	5399.7
	=	66.19 %

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Pfizer (NSE:PFIZER) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Pfizer had a gross margin of 66.19% for the quarter that ended in Dec. 2023 => Durable competitive advantage

Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.

Pfizer Gross Margin % Related Terms

Thank you for viewing the detailed overview of Pfizer's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Pfizer (NSE:PFIZER) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pfizer Ltd (NSE:PFIZER) » Definitions » Gross Margin %

Comparable Companies

Traded in Other Exchanges

500680:India

Address

The Capital, 1802/1901, 18th Floor, Plot No. C - 70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai, MH, IND, 400 051

Website

https://www.pfizerltd.co.in

Pfizer Ltd is a major drug manufacturing company that focuses on a global portfolio of medical products. The company works across developed and emerging markets to advance treatments through its two segments, Pfizer Innovative Health and Pfizer Essential Health. The vast majority of the company's revenue is derived from the manufacture and sale of biopharmaceutical products. most of the company's sales are generated by its Innovative Health segment. While the company operates across a wide span of international markets, most of the company's revenue is generated in India.

Pfizer (NSE:PFIZER) Headlines

No Headlines